Additionally, MIF sustains tumor cell viability through the AKT survival pathway via an autocrine feedback loop [80], and promotes angiogenesis through HIF1α-dependent signaling or the NFκB–IL8–VEGF axis, as reported in several tumor models [77, 81]. The gene discussed is NFKB1; the disease is neoplasm.